ZAFBENA
Live / Allowed — Fifth extension granted (statement of use) (as of 10 Dec 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 20 Dec 2021 filing date already counts against anyone who files later.
Record
- Serial number
- 97180767
- Mark type
- Word mark
- Filed
- 20 Dec 2021
- Published for opposition
- 01 Nov 2022
- Attorney of record
- Virginia W. Marino
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in oncology and pharmaceutical preparations to treat cancer
Owner
- BendaRx Corp., Alexandria, VA, US
- BendaRx Corp., Alexandria, VA, US
Prosecution history
- 11 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2025 — SOU EXTENSION 5 GRANTED
- 24 Jun 2025 — SOU EXTENSION 5 FILED
- 10 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2024 — SOU EXTENSION 4 GRANTED
- 09 Dec 2024 — SOU EXTENSION 4 FILED
- 09 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2024 — SOU EXTENSION 3 GRANTED
- 24 Jun 2024 — SOU EXTENSION 3 FILED
- 24 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Dec 2023 — SOU EXTENSION 2 GRANTED